Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5206)
All Articles published online
|
Nov 14, 2008 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ustundag Y, Bayraktar Y. Cholangiocarcinoma: A compact review of the literature. World J Gastroenterol 2008; 14(42): 6458-6466 [PMID: 19030196 DOI: 10.3748/wjg.14.6458] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i42/6458.htm |
| Number | Citing Articles |
| 1 |
Zhiliang Wu, Thidarut Boonmars, Isao Nagano, Watcharin Loilome, Puangrat Yongvanit, Narong Khuntikeo, Phuangphaka Sadee Nielsen, Chawalit Paorojkul, Yuzo Takahashi, Yoichi Maekawa. Milk fat globule epidermal growth factor 8 serves a novel biomarker of opisthorchiasis-associated cholangiocarcinoma. Tumor Biology 2014; 35(3): 1985 doi: 10.1007/s13277-013-1264-3
|
| 2 |
Alexander Arnold, Marcus Bahra, Dido Lenze, Maren Bradtmöller, Katrin Guse, Claire Gehlhaar, Hendrik Bläker, Frank L. Heppner, Arend Koch. Genome wide DNA copy number analysis in cholangiocarcinoma using high resolution molecular inversion probe single nucleotide polymorphism assay. Experimental and Molecular Pathology 2015; 99(2): 344 doi: 10.1016/j.yexmp.2015.08.003
|
| 3 |
Giovanni Brandi, Michela Venturi, Maria Abbondanza Pantaleo, Giorgio Ercolani, Lorenzo Fornaro, Nicola Silvestris, Francesco Leone, Enrico Vasile, Sara Lonardi, Stefano Cereda, Daniele Santini, Giuseppe Aprile. Cholangiocarcinoma: Current opinion on clinical practice diagnostic and therapeutic algorithms. Digestive and Liver Disease 2016; 48(3): 231 doi: 10.1016/j.dld.2015.11.017
|
| 4 |
Chiao-En Wu, Wen-Chi Chou, Chia-Hsun Hsieh, John Wen-Cheng Chang, Cheng-Yu Lin, Chun-Nan Yeh, Jen-Shi Chen. Prognostic and predictive factors for Taiwanese patients with advanced biliary tract cancer undergoing frontline chemotherapy with gemcitabine and cisplatin: a real-world experience. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-06914-1
|
| 5 |
Ming-Huang Chen, Kun-Chun Chiang, Chi-Tung Cheng, Shih-Chiang Huang, Yeng-Yang Chen, Tsung-Wen Chen, Ta-Sen Yeh, Yi-Yin Jan, Hsi-Ming Wang, Jiang-Jie Weng, Peter Mu-Hsin Chang, Chun-Yu Liu, Chung-Pin Li, Yee Chao, Ming-Han Chen, Chi-Ying F. Huang, Chun-Nan Yeh. Antitumor activity of the combination of an HSP90 inhibitor and a PI3K/mTOR dual inhibitor against cholangiocarcinoma. Oncotarget 2014; 5(9): 2372 doi: 10.18632/oncotarget.1706
|
| 6 |
Raju Bandu, Hyuck Jun Mok, Kwang Pyo Kim. Phospholipids as cancer biomarkers: Mass spectrometry‐based analysis. Mass Spectrometry Reviews 2018; 37(2): 107 doi: 10.1002/mas.21510
|
| 7 |
Mette Enok Munk Lauridsen, Frank V. Mortensen, Dennis T. Nielsen, Henning Grønbæk. Creation of a Fistula Between the Hepatic Duct and the Gastric Lumen by way of Percutaneus Transhepatic Cholangiography: A Case Report. Journal of Gastrointestinal Cancer 2012; 43(2): 354 doi: 10.1007/s12029-010-9212-6
|
| 8 |
Vijay K. Maker, Edgar D. Guzman-Arrieta. Cognitive Pearls in General Surgery. 2015; : 331 doi: 10.1007/978-1-4939-1850-8_17
|
| 9 |
Shin-Yi Chung, Yi-Ping Hung, Yi-Ru Pan, Yu-Chan Chang, Chiao-En Wu, Dennis Shin-Shian Hsu, Peter Mu-Hsin Chang, Meng-Lun Lu, Chi-Ying F. Huang, Yeu Su, Michael Hsiao, Chun-Nan Yeh, Ming-Huang Chen. Ruxolitinib Combined with Gemcitabine against Cholangiocarcinoma Growth via the JAK2/STAT1/3/ALDH1A3 Pathway. Biomedicines 2021; 9(8): 885 doi: 10.3390/biomedicines9080885
|
| 10 |
Vivek Bhakta Mathema, Kesara Na-Bangchang. Current Insights on Cholangiocarcinoma Research: a Brief Review. Asian Pacific Journal of Cancer Prevention 2015; 16(4): 1307 doi: 10.7314/APJCP.2015.16.4.1307
|
| 11 |
Wansika Phadungsil, Supaporn Pumpa, Kridsada Sirisabhabhorn, Amornrat Geadkaew-Krenc, Rudi Grams, Mathirut Mungthin, Toon Ruang-Areerate, Poom Adisakwattana, Nipawan Labbunruang, Pongsakorn Martviset, Pedro P. Chieffi. Efficiency of the Stool-PCR Test Targeting NADH Dehydrogenase (Nad) Subunits for Detection of Opisthorchis viverrini Eggs. Journal of Tropical Medicine 2021; 2021: 1 doi: 10.1155/2021/3957545
|
| 12 |
Subhankar Chakraborty, Michael J. Baine, Aaron R. Sasson, Surinder K. Batra. Current status of molecular markers for early detection of sporadic pancreatic cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2011; 1815(1): 44 doi: 10.1016/j.bbcan.2010.09.002
|
| 13 |
Eleni Gkika, Maria A. Hawkins, Anca-Ligia Grosu, Thomas B. Brunner. The Evolving Role of Radiation Therapy in the Treatment of Biliary Tract Cancer. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.604387
|
| 14 |
Ting‐Tsung Chang, Ji‐Hong Cheng, Hung‐Wen Tsai, Kung‐Chia Young, Sun‐Yuan Hsieh, Cheng‐Hsun Ho. Plasma proteome plus site‐specific N‐glycoprofiling for hepatobiliary carcinomas. The Journal of Pathology: Clinical Research 2019; 5(3): 199 doi: 10.1002/cjp2.136
|
| 15 |
Thidarut Boonmars, Zhiliang Wu, Sirintip Boonjaruspinyo, Somchai Pinlaor, Isao Nagano, Yuzo Takahashi, Butsara Kaewsamut, Puangrat Yongvanit. Alterations of gene expression of RB pathway in Opisthorchis viverrini infection-induced cholangiocarcinoma. Parasitology Research 2009; 105(5): 1273 doi: 10.1007/s00436-009-1548-0
|
| 16 |
Pathanin Chantree, Sirilak Chumkiew, Mantana Jamklang, Pongsakorn Martviset. Cytotoxic activities of ethanolic crude extracts from fruiting bodies of bamboo mushrooms (Dictyophora spp.) against cholangiocarcinoma cells. Research Results in Pharmacology 2022; 8(1): 33 doi: 10.3897/rrpharmacology.8.72098
|
| 17 |
Kazuhiro Toyota, Yoshiaki Murakami, Naru Kondo, Kenichiro Uemura, Naoya Nakagawa, Shinya Takahashi, Taijiro Sueda. Cytoplasmic Hu-Antigen R (HuR) Expression is Associated with Poor Survival in Patients with Surgically Resected Cholangiocarcinoma Treated with Adjuvant Gemcitabine-Based Chemotherapy. Annals of Surgical Oncology 2018; 25(5): 1202 doi: 10.1245/s10434-018-6392-y
|
| 18 |
Maria Maddalena Simile, Paola Bagella, Gianpaolo Vidili, Angela Spanu, Roberto Manetti, Maria Antonietta Seddaiu, Sergio Babudieri, Giordano Madeddu, Pier Andrea Serra, Matteo Altana, Panagiotis Paliogiannis. Targeted Therapies in Cholangiocarcinoma: Emerging Evidence from Clinical Trials. Medicina 2019; 55(2): 42 doi: 10.3390/medicina55020042
|
| 19 |
Kesara Na-Bangchang, Tullayakorn Plengsuriyakarn, Juntra Karbwang, Carmen Mannucci. Research and Development of Atractylodes lancea (Thunb) DC. as a Promising Candidate for Cholangiocarcinoma Chemotherapeutics. Evidence-Based Complementary and Alternative Medicine 2017; 2017(1) doi: 10.1155/2017/5929234
|
| 20 |
Shosei Shimizu, Toshiyuki Okumura, Yoshiko Oshiro, Nobuyoshi Fukumitsu, Kuniaki Fukuda, Kazunori Ishige, Naoyuki Hasegawa, Haruko Numajiri, Keiko Murofushi, Kayoko Ohnishi, Masashi Mizumoto, Tetsuo Nonaka, Hitoshi Ishikawa, Hideyuki Sakurai. Clinical outcomes of previously untreated patients with unresectable intrahepatic cholangiocarcinoma following proton beam therapy. Radiation Oncology 2019; 14(1) doi: 10.1186/s13014-019-1451-5
|
| 21 |
Vivek B Mathema, Wanna Chaijaroenkul, Juntra Karbwang, Kesara Na‐Bangchang. Growth inhibitory effect of β‐eudesmol on cholangiocarcinoma cells and its potential suppressive effect on heme oxygenase‐1 production, STAT1/3 activation, and NF‐κB downregulation. Clinical and Experimental Pharmacology and Physiology 2017; 44(11): 1145 doi: 10.1111/1440-1681.12818
|
| 22 |
Jin Lee, Eun Mi Hong, Ju Ah Jang, Se Woo Park, Dong Hee Koh, Min Ho Choi, Hyun Joo Jang, Sea Hyub Kae. Simvastatin Induces Apoptosis and Suppresses Insulin-Like Growth Factor 1 Receptor in Bile Duct Cancer Cells. Gut and Liver 2016; 10(2): 310 doi: 10.5009/gnl15195
|
| 23 |
Ting-Tsung Chang, Hung-Wen Tsai, Cheng-Hsun Ho. Fucosyl-Agalactosyl IgG1 Induces Cholangiocarcinoma Metastasis and Early Recurrence by Activating Tumor-Associated Macrophage. Cancers 2018; 10(11): 460 doi: 10.3390/cancers10110460
|
| 24 |
Gerbail T. Krishnamurthy, Shakuntala Krishnamurthy. Nuclear Hepatology. 2009; : 341 doi: 10.1007/978-3-642-00648-7_12
|
| 25 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_28-1
|
| 26 |
Y Malad, D A Kartini, P Karoon, S Suayod, K Waree, T Tippayamontri, T Sanghangthum, C Talubnin, C Kobdaj.
In vitro studies of Cholangiocarcinoma cell lines response to X-rays and Neutron irradiation. Journal of Physics: Conference Series 2023; 2653(1): 012074 doi: 10.1088/1742-6596/2653/1/012074
|
| 27 |
Miguel Garcia-Pardo, Laura Ortega, María Jesús Fernández-Aceñero, Pilar García Alfonso, Miguel Martín, Andrés J Muñoz. Molecular Profiling and Targeted Therapy in Cholangiocarcinoma: An Observational, Retrospective Multicenter Study. Journal of Gastrointestinal Cancer 2021; 52(2): 814 doi: 10.1007/s12029-021-00622-0
|
| 28 |
Amrita Sethi, Douglas A. Howell. Clinical Gastrointestinal Endoscopy. 2019; : 699 doi: 10.1016/B978-0-323-41509-5.00060-8
|
| 29 |
Tullayakorn Plengsuriyakarn, Veerachai Eursitthichai, Nipawan Labbunruang, Kesara Na-Bangchang, Smarn Tesana, Waraporn Aumarm, Ananya Pongpradit, Vithoon Viyanant. Ultrasonography as a Tool for Monitoring the Development and Progression of Cholangiocarcinoma in Opisthorchis viverrini/Dimethylnitrosamine-Induced Hamsters. Asian Pacific Journal of Cancer Prevention 2012; 13(1): 87 doi: 10.7314/APJCP.2012.13.1.087
|
| 30 |
BING WANG, HONGBO LI, RUI YANG, SHUNCHANG ZHOU, SHENGQUAN ZOU. Decitabine inhibits the cell growth of cholangiocarcinoma in cultured cell lines and mouse xenografts. Oncology Letters 2014; 8(5): 1919 doi: 10.3892/ol.2014.2499
|
| 31 |
Joo Hyun Lee, Han Gyul Kim, Ju-Hee Oh, Young-Joo Lee. Dramatic increase in hepatic and biliary curcumin exposure by modulation of its elimination pathway in rats. Journal of Pharmacy and Pharmacology 2013; 65(3): 423 doi: 10.1111/j.2042-7158.2012.01610.x
|
| 32 |
Chun-Nan Yeh, Yu-Chan Chang, Yeu Su, Dennis Shin-Shian Hsu, Chi-Tung Cheng, Ren-Chin Wu, Yi-Hsiu Chung, Kun-Chun Chiang, Ta-Sen Yeh, Meng-Lun Lu, Chun-Yu Liu, Peter Mu-Hsin Chang, Ming-Han Chen, Chi-Ying F. Huang, Michael Hsiao, Ming-Huang Chen. Identification of MALT1 as both a prognostic factor and a potential therapeutic target of regorafenib in cholangiocarcinoma patients. Oncotarget 2017; 8(69): 113444 doi: 10.18632/oncotarget.23049
|
| 33 |
Tian Tian, Zhiming Zhu, Yalong Ding, Guoli Li, Nan Li, Tong Shen. Synthesis and Cytotoxic Evaluation of Sanjoseolide and Representative Analogues. ACS Omega 2020; 5(51): 33478 doi: 10.1021/acsomega.0c05546
|
| 34 |
Xin Yu Li, Jia Qi Chen, Adilai Aisa, Yu Wei Ding, Ding Zhang, Ying Yuan. Targeting BRCA‐mutant biliary tract cancer: Current evidence and future perspectives. Journal of Digestive Diseases 2023; 24(2): 85 doi: 10.1111/1751-2980.13168
|
| 35 |
Fanyin Meng, Yuyan Han, Dustin Staloch, Taylor Francis, Allison Stokes, Heather Francis. The H4 histamine receptor agonist, clobenpropit, suppresses human cholangiocarcinoma progression by disruption of epithelial mesenchymal transition and tumor metastasis. Hepatology 2011; 54(5): 1718 doi: 10.1002/hep.24573
|
| 36 |
Annika Bergquist, Erik von Seth. Epidemiology of cholangiocarcinoma. Best Practice & Research Clinical Gastroenterology 2015; 29(2): 221 doi: 10.1016/j.bpg.2015.02.003
|
| 37 |
Zhiliang Wu, Thidarut Boonmars, Isao Nagano, Sirintip Boonjaraspinyo, Somchai Pinlaor, Chawalit Pairojkul, Yaovalux Chamgramol, Yuzo Takahashi. Alteration of galectin-1 during tumorigenesis of Opisthorchis viverrini infection-induced cholangiocarcinoma and its correlation with clinicopathology. Tumor Biology 2012; 33(4): 1169 doi: 10.1007/s13277-012-0360-0
|
| 38 |
Manju D. Chandrasegaram, John W. Chen, Timothy J. Price, John Zalcberg, Katrin Sjoquist, Neil D. Merrett. Advances in Molecular Pathology and Treatment of Periampullary Cancers. Pancreas 2016; 45(1): 32 doi: 10.1097/MPA.0000000000000385
|
| 39 |
Piyapan Prueksapanich, Panida Piyachaturawat, Prapimphan Aumpansub, Wiriyaporn Ridtitid, Roongruedee Chaiteerakij, Rungsun Rerknimitr. Liver Fluke-Associated Biliary Tract Cancer. Gut and Liver 2018; 12(3): 236 doi: 10.5009/gnl17102
|
| 40 |
Maryam Makki, Malak Bentaleb, Mohammed Abdulrahman, Amal Abdulla Suhool, Salem Al Harthi, Marcelo AF Ribeiro Jr. Current interventional options for palliative care for patients with advanced-stage cholangiocarcinoma. World Journal of Clinical Oncology 2024; 15(3): 381-390 doi: 10.5306/wjco.v15.i3.381
|
| 41 |
Zehra Nur Caliskan, Merve Ozel Yetkin, Mevlut Baskol, Gulden Baskol. Effect of silibinin on GAS6/sAXL and JAK/STAT pathways in human cholangiocarcinoma cell line. Turkish Journal of Biochemistry 2024; 49(5): 637 doi: 10.1515/tjb-2022-0275
|
| 42 |
Zhiliang Wu, Thidarut Boonmars, Sirintip Boonjaraspinyo, Isao Nagano, Somchai Pinlaor, Anucha Puapairoj, Puangrat Yongvanit, Yuzo Takahashi. Candidate genes involving in tumorigenesis of cholangiocarcinoma induced by Opisthorchis viverrini infection. Parasitology Research 2011; 109(3): 657 doi: 10.1007/s00436-011-2298-3
|
| 43 |
Ming-Huang Chen, Chueh-Chuan Yen, Chi-Tung Cheng, Ren-Chin Wu, Shih-Chiang Huang, Chung-Shan Yu, Yi-Hsiu Chung, Chun-Yu Liu, Peter Mu-Hsin Chang, Yee Chao, Ming-Han Chen, Yu-Fen Chen, Kun-Chun Chiang, Ta-Sen Yeh, Tzu Chi Chen, Chi-Ying F. Huang, Chun-Nan Yeh. Identification of SPHK1 as a therapeutic target and marker of poor prognosis in cholangiocarcinoma. Oncotarget 2015; 6(27): 23594 doi: 10.18632/oncotarget.4335
|
| 44 |
Yi-Ru Pan, Chiao-En Wu, Ming-Huang Chen, Wen-Kuan Huang, Hsuan-Jen Shih, Keng-Li Lan, Chun-Nan Yeh. Comprehensive Evaluation of Immune-Checkpoint DNA Cancer Vaccines in a Rat Cholangiocarcinoma Model. Vaccines 2020; 8(4): 703 doi: 10.3390/vaccines8040703
|
| 45 |
Dong Kuang, Guo-Ping Wang. Hilar cholangiocarcinoma: Pathology and tumor biology. Frontiers of Medicine in China 2010; 4(4): 371 doi: 10.1007/s11684-010-0130-6
|
| 46 |
Min-Hua Chen, Po-Chin Liang, Kai-Chun Chang, Jian-Yuan Huang, Yu-Ting Chang, Fuh-Yu Chang, Jau-Min Wong, Feng-Huei Lin. Prototype of biliary drug-eluting stent with photodynamic and chemotherapy using electrospinning. BioMedical Engineering OnLine 2014; 13(1) doi: 10.1186/1475-925X-13-118
|
| 47 |
Ming-ming Xu, Amrita Sethi. Diagnosing Biliary Malignancy. Gastrointestinal Endoscopy Clinics of North America 2015; 25(4): 677 doi: 10.1016/j.giec.2015.06.011
|
| 48 |
Carsten Kamphues, D. Seehofer, R. M. Eisele, T. Denecke, J. Pratschke, U. P. Neumann, P. Neuhaus. Recurrent intrahepatic cholangiocarcinoma: single‐center experience using repeated hepatectomy and radiofrequency ablation. Journal of Hepato-Biliary-Pancreatic Sciences 2010; 17(4): 509 doi: 10.1007/s00534-009-0256-6
|
| 49 |
Chiao-En Wu, Wen-Kuan Huang, Wen-Chi Chou, Chia-Hsun Hsieh, John Wen-Cheng Chang, Cheng-Yu Lin, Chun-Nan Yeh, Jen-Shi Chen. Establishment of a Pretreatment Nomogram to Predict the 6-Month Mortality Rate of Patients with Advanced Biliary Tract Cancers Undergoing Gemcitabine-Based Chemotherapy. Cancers 2021; 13(13): 3139 doi: 10.3390/cancers13133139
|
| 50 |
Rong Hua, Jun-feng Zhang, Wei Liu, Yan-miao Huo, Yong-wei Sun. Signet-ring cell carcinoma coexisting with adenocarcinoma arising in a choledochal cyst: report of a case. Surgery Today 2015; 45(8): 1049 doi: 10.1007/s00595-014-1049-3
|
| 51 |
Jin-Seok Park, Don Haeng Lee, Seok Jeong, Woo Chul Kim, Jung Il Lee, Seung Yun Lee, Sang Don Park, So-Yun Nha. Concurrent Chemoradiation in a Patient with Unresectable Cholangiocarcinoma. Gut and Liver 2010; 4(1): 103 doi: 10.5009/gnl.2010.4.1.103
|
| 52 |
Cody R. Criss, Mina S. Makary. Recent Advances in Image-Guided Locoregional Therapies for Primary Liver Tumors. Biology 2023; 12(7): 999 doi: 10.3390/biology12070999
|
| 53 |
Manuela Gatto, Maria Consiglia Bragazzi, Rossella Semeraro, Cristina Napoli, Raffaele Gentile, Alessia Torrice, Eugenio Gaudio, Domenico Alvaro. Cholangiocarcinoma: Update and future perspectives. Digestive and Liver Disease 2010; 42(4): 253 doi: 10.1016/j.dld.2009.12.008
|
| 54 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 527 doi: 10.1007/978-3-319-26956-6_28
|
| 55 |
Eun Young Lee, Chan Kim, Min-Joo Kim†, Jung-Yeop Park, Seung-Woo Park, Si-Young Song, Jae-Bock Chung, Hogeun Kim†, Seungmin Bang. Signet Ring Cell Carcinoma of the Extrahepatic Bile Duct. Gut and Liver 2010; 4(3): 402 doi: 10.5009/gnl.2010.4.3.402
|
| 56 |
Vivek B Mathema, Wanna Chaijaroenkul, Kesara Na-Bangchang. Cytotoxic activity and molecular targets of atractylodin in cholangiocarcinoma cells. Journal of Pharmacy and Pharmacology 2019; 71(2): 185 doi: 10.1111/jphp.13024
|
| 57 |
Ming‐Huang Chen, Kun‐Ju Lin, Wu‐Lung R. Yang, Ya‐Wen Kao, Tsung‐Wen Chen, Shu‐Chaou Chao, Peter Mu‐Hsin Chang, Chun‐Yu Liu, Cheng‐Hwai Tzeng, Yee Chao, Ming‐Han Chen, Chun‐Nan Yeh, Chi‐Ying F. Huang. Gene expression‐based chemical genomics identifies heat‐shock protein 90 inhibitors as potential therapeutic drugs in cholangiocarcinoma. Cancer 2013; 119(2): 293 doi: 10.1002/cncr.27743
|
| 58 |
Abdulrahman Y. Hammad, Nicholas G. Berger, T. Clark Gamblin. Pancreas and Biliary Disease. 2016; : 287 doi: 10.1007/978-3-319-28089-9_13
|
| 59 |
Niv Pencovich, Muhammad Younis, Yonatan Lessing, Lilach Zac, Joseph B. Lessing, Yariv Yogev, Michael J. Kupferminc, Ido Nachmany. Major liver resection in pregnancy: three cases with different etiologies and review of the literature. The Journal of Maternal-Fetal & Neonatal Medicine 2019; 32(2): 203 doi: 10.1080/14767058.2017.1376315
|
| 60 |
Richard A. Kozarek. Inflammation and Carcinogenesis of the Biliary Tract: Update On Endoscopic Treatment. Clinical Gastroenterology and Hepatology 2009; 7(11): S89 doi: 10.1016/j.cgh.2009.08.026
|
| 61 |
Chiao-En Wu, Yi-Ru Pan, Chun-Nan Yeh, John Lunec. Targeting P53 as a Future Strategy to Overcome Gemcitabine Resistance in Biliary Tract Cancers. Biomolecules 2020; 10(11): 1474 doi: 10.3390/biom10111474
|
| 62 |
Paulina Chinchilla-López, Nancy E. Aguilar-Olivos, Jaime García-Gómez, Karen K. Hernández-Alejandro, Fredy Chablé-Montero, Daniel Motola-Kuba, Tushar Patel, Nahum Méndez-Sánchez. Prevalence, Risk Factors, and Survival of Patients with Intrahepatic Cholangiocarcinoma. Annals of Hepatology 2017; 16(4): 565 doi: 10.5604/01.3001.0010.0293
|
| 63 |
Mihai Ranete, Mugur C. Grasu, Radu Dumitru, Gina Rusu, Mihai Toma, Ioana G. Lupescu. Overview of intrahepatic cholangiocarcinoma – from imaging aspects to interventional approach. Oncolog-Hematolog.ro 2019; 4(49): 16 doi: 10.26416/OnHe.49.4.2019.2738
|
| 64 |
Aditya Borakati, Farid Froghi, Ricky H Bhogal, Vasileios K Mavroeidis. Stereotactic radiotherapy for intrahepatic cholangiocarcinoma. World Journal of Gastrointestinal Oncology 2022; 14(8): 1478-1489 doi: 10.4251/wjgo.v14.i8.1478
|
| 65 |
Valérie Untereiner, Ganesh Dhruvananda Sockalingum, Roselyne Garnotel, Cyril Gobinet, Fidy Ramaholimihaso, Florent Ehrhard, Marie‐Danièle Diebold, Gérard Thiéfin. Bile analysis using high‐throughput FTIR spectroscopy for the diagnosis of malignant biliary strictures: a pilot study in 57 patients. Journal of Biophotonics 2014; 7(3-4): 241 doi: 10.1002/jbio.201300166
|
| 66 |
SI-HONG YOU, XIANG WANG, SHU HUANG, MIN WANG, GUO-ZHONG JI, JIN-RONG XIA, ZHI-NING FAN. MYH rs3219476 and rs3219472 polymorphisms and risk of cholangiocarcinoma. Molecular Medicine Reports 2013; 7(1): 347 doi: 10.3892/mmr.2012.1175
|
| 67 |
Yavuz Beyazit, Tugrul Purnak, Burak Suvak, Mevlut Kurt, Abdurrahim Sayilir, Turan Turhan, Adnan Tas, Serkan Torun, Tugrul Celik, Mehmet Ibis, Ibrahim C. Haznedaroglu. Increased ACE in extrahepatic cholangiocarcinoma as a clue for activated RAS in biliary neoplasms. Clinics and Research in Hepatology and Gastroenterology 2011; 35(10): 644 doi: 10.1016/j.clinre.2011.06.008
|
| 68 |
Thorsten O. Goetze, Wolf O. Bechstein, Ulli Simone Bankstahl, Tobias Keck, Alfred Königsrainer, Sven A. Lang, Claudia Pauligk, Pompiliu Piso, Arndt Vogel, Salah-Eddin Al-Batran. Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in incidentally detected gallbladder carcinoma after simple cholecystectomy or in front of radical resection of BTC (ICC/ECC) – a phase III study of the German registry of incidental gallbladder carcinoma platform (GR)– the AIO/ CALGP/ ACO- GAIN-trial –. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-6610-4
|
| 69 |
Dana M Lindemann, David Eshar, Denise Lin, Sanjeev K Narayanan. Cholangiocarcinoma with concurrent ovarian adenocarcinoma in a green iguana (Iguana iguana). Companion Animal 2017; 22(3): 162 doi: 10.12968/coan.2017.22.3.162
|
| 70 |
Peter Chang, Chi‑Tung Cheng, Ren‑Chin Wu, Yi‑Hsiu Chung, Kun‑Chun Chiang, Ta‑Sen Yeh, Chun‑Yu Liu, Ming‑Han Chen, Ming‑Huang Chen, Chun‑Nan Yeh. Nab‑paclitaxel is effective against intrahepatic cholangiocarcinoma via disruption of desmoplastic stroma. Oncology Letters 2018; doi: 10.3892/ol.2018.8690
|
| 71 |
Abraham Levitin, Matthew Tam, Karunakaravel Karuppasamy, Raghid Kikano. Supportive Oncology. 2011; : 382 doi: 10.1016/B978-1-4377-1015-1.00036-9
|
| 72 |
Lindsey Kennedy, Kimberly Baker, Kyle Hodges, Allyson Graf, Julie Venter, Laura Hargrove, Rachel Harris, Evan Harnish, Fanyin Meng, Heather Francis. Dysregulation of vitamin D3 synthesis leads to enhanced cholangiocarcinoma growth. Digestive and Liver Disease 2013; 45(4): 316 doi: 10.1016/j.dld.2012.12.012
|
| 73 |
Ömer Dizdar, Saadettin Kılıçkap. Textbook of Gastrointestinal Oncology. 2019; : 1 doi: 10.1007/978-3-030-18890-0_1
|
| 74 |
Nasim Parsa, Mouen A. Khashab. The Role of Peroral Cholangioscopy in Evaluating Indeterminate Biliary Strictures. Clinical Endoscopy 2019; 52(6): 556 doi: 10.5946/ce.2019.011
|
| 75 |
Prakongboon Sungkasubun, Surachate Siripongsakun, Kunlayanee Akkarachinorate, Sirachat Vidhyarkorn, Akeanong Worakitsitisatorn, Thaniya Sricharunrat, Sutida Singharuksa, Rawisak Chanwat, Chairat Bunchaliew, Sirima Charoenphattharaphesat, Ruechuta Molek, Maneenop Yimyaem, Gaidganok Sornsamdang, Kamonwan Soonklang, Kasiruck Wittayasak, Chirayu U. Auewarakul, Chulabhorn Mahidol. Ultrasound screening for cholangiocarcinoma could detect premalignant lesions and early-stage diseases with survival benefits: a population-based prospective study of 4,225 subjects in an endemic area. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2390-2
|
| 76 |
RENUMATHY DHANASEKARAN, ALAN W. HEMMING, IVAN ZENDEJAS, THOMAS GEORGE, DAVID R. NELSON, CONSUELO SOLDEVILA-PICO, ROBERTO J. FIRPI, GIUSEPPE MORELLI, VIRGINIA CLARK, RONIEL CABRERA. Treatment outcomes and prognostic factors of intrahepatic cholangiocarcinoma. Oncology Reports 2013; 29(4): 1259 doi: 10.3892/or.2013.2290
|
| 77 |
James Yu, Amit Mahipal, Richard Kim. Targeted Therapy for Advanced or Metastatic Cholangiocarcinoma: Focus on the Clinical Potential of Infigratinib. OncoTargets and Therapy 2021; : 5145 doi: 10.2147/OTT.S272208
|
| 78 |
Ming-Huang Chen, Jing-Jie Weng, Chi-Tung Cheng, Ren-Chin Wu, Shih-Chiang Huang, Chiao-En Wu, Yi-Hsiu Chung, Chun-Yu Liu, Mu-Hsin Chang, Ming-Han Chen, Kun-Chun Chiang, Ta-Sen Yeh, Yeu Su, Chun-Nan Yeh. ALDH1A3, the Major Aldehyde Dehydrogenase Isoform in Human Cholangiocarcinoma Cells, Affects Prognosis and Gemcitabine Resistance in Cholangiocarcinoma Patients. Clinical Cancer Research 2016; 22(16): 4225 doi: 10.1158/1078-0432.CCR-15-1800
|
| 79 |
Alexandre Dos Santos, Magali Court, Valérie Thiers, Sokhavuth Sar, Catherine Guettier, Didier Samuel, Christian Bréchot, Jérôme Garin, France Demaugre, Christophe D. Masselon. Identification of Cellular Targets in Human Intrahepatic Cholangiocarcinoma Using Laser Microdissection and Accurate Mass and Time Tag Proteomics. Molecular & Cellular Proteomics 2010; 9(9): 1991 doi: 10.1074/mcp.M110.000026
|
| 80 |
Mohammed Abu Hilal, AbdAllah Badran, Francesco Di Fabio, Neil William Pearce. Pure Laparoscopic En Bloc Left Hemihepatectomy and Caudate Lobe Resection in Patients with Intrahepatic Cholangiocarcinoma. Journal of Laparoendoscopic & Advanced Surgical Techniques 2011; 21(9): 845 doi: 10.1089/lap.2011.0247
|
| 81 |
Teng-Yu Lee, Jaw-Town Lin, Ken N. Kuo, Ming-Shiang Wu, Hsiu J. Ho, Tzu-Ting Chen, Chun-Ying Wu. A nationwide population-based study shows increasing incidence of cholangiocarcinoma. Hepatology International 2013; 7(1): 226 doi: 10.1007/s12072-012-9369-0
|
| 82 |
Eva Braunwarth, Stefan Stättner, Margot Fodor, Benno Cardini, Thomas Resch, Rupert Oberhuber, Daniel Putzer, Reto Bale, Manuel Maglione, Christian Margreiter, Stefan Schneeberger, Dietmar Öfner, Florian Primavesi. Surgical techniques and strategies for the treatment of primary liver tumours: hepatocellular and cholangiocellular carcinoma. European Surgery 2018; 50(3): 100 doi: 10.1007/s10353-018-0537-x
|
| 83 |
Alexander Stein, Dirk Arnold, John Bridgewater, David Goldstein, Lars Henrik Jensen, Heinz-Josef Klümpen, Ansgar W. Lohse, Björn Nashan, John Primrose, Silke Schrum, Jenny Shannon, Eik Vettorazzi, Henning Wege. Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial. BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1498-0
|